Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015664

Options or other derivatives

  • Chief Financial Officer acquired 317,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Foster Jonathan P. Chief Financial Officer 2022-06-20 Grant or award · Stock option (right to buy) +155,000 571,438 D
Foster Jonathan P. Chief Financial Officer 2022-06-20 Grant or award · Restricted Stock Units +162,667 734,105 D
Loading xslF345X03/rdgdoc.xml…